common cause of acquired epilepsy worldwide. Seizures are the most common manifestation, present in 70-90% of symptomatic patients. 1 NCC has primarily been a disease that remains endemic in less economically developed countries; however, because of globalization, NCC is now being diagnosed more frequently in high-income countries. 2 A set of diagnostic criteria for NCC has been proposed and revisited. These criteria are useful for maintaining uniformity, particularly for research. 3, 4 Absolute criteria include direct visualization of parasite, histological demonstration of parasite or evidence of cystic lesion with scolex on CT or magnetic resonance imaging. The disease can be parenchymal, occurring in the brain substance, or extraparenchymal, occurring in the ventricles, basilar cisterns, or subarachnoid space of the brain or in the spinal cord. The scolex is visualized as a bright, extramural nodule within the cyst (hole with dot appearance). Parenchymal NCC has four stages: vesicular; colloidal vesicular; granular nodular; and nodular calcified. When multiple cysts in different stages of evolution are visible it gives rise to the "starry-sky" appearance, which is typical of NCC. Emergency therapeutic interventions are aimed at managing the neurological complications, which include anticonvulsant therapy, corticosteroids, neurosurgical intervention and/or treatment of increased intracranial pressure. Cysticidal therapy is indicated with antihelminthics (albendazole or praziquantel), but must be administered with caution because larval death provokes an inflammatory response that may increase symptoms. Concomitant steroids are usually indicated. Treatment with cysticidal therapy leads to reduction in seizure frequency and a faster resolution of lesions.
Documented patient informed consent and/or Institutional Review Board approval has been obtained and filed for publication of this case report.
